»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ V)>?[
Y-a
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 N8dxgh!,
=#S.t:HQ*
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© =zcvR {Dkp
1.Antigen presenting cell£¨APC£© 2.Qz"YDh
=
2.Activation induced cell death£¨AICD£©
lFyDH{!
3.Chemokine }Pg}"fb^
4.Major histocompatibility complex£¨MHC£© hcj}6NXc
5.immunotolerance SscB&{f
!{t|z=Qg
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© 1^}I?PbqV
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ -$Hu$Y}>
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà d}h{#va*
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ MVsFi]-
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ WK>|IgK
5.±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌصã
>Q\Kc=Q|
]$@D=g,r
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© o3 fc -
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ 2M-[x"\1/
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ |h\7Q1,1~2
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ 3S:Lce'f
J, 9NVw$
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ N7+L@CC6T
5QMra5N k
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 6st
{ar
qcILr
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ (jM0YtrD
1.Antigenic determinant *|fF;-#v
2.IgSF ^Co$X+
3.MBL;¾¶ WTJ
0Q0U
4.chemokine gsk?
!D
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ J?QS7#!%
6.TCR-CD3¸´ºÏÎï ]%' AZ`8
7.FADD£¨Fas-associated protein with death domain£© 'r?ULft1
8.AIDS /,Xl8<~#
9.Tumor rejection antigen
d~LoHp
10.AICD z%82Vt!a5
b dgkA
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ FZr/trP~
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© )/T[Cnx.Nc
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ ,QY$:f<
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ VfX^iG r
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì jx: IK
;w7 mr1
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ l|P"^;*zq
N~
v
6K}`}
:GXF=Df
רҵ¿Î ÃâÒßѧ _%w680b'
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê #De>EQ%
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell `2mddx8
5. Fc¦Å receptor 6. Cytokine 2Y
vr|] \8
¶þ¡¢ ÎÊ´ðÌâ l4bytI{63
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØɱÉË°Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 U\KMeaF5e-
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ NAGM3{\5v$
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁÜ°ÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ nf.Ox.kM)
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâЩÌصãµÄÉúÎïѧÒâÒ壿 9`tK9
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦ÓᣠC8U3+ s
IPQRdBQ
Y6` xb`
VmS_(bM
n5:uG'L\
{w@qFE'b
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ Q Be6\oq
:gVUk\)
W__ArV2Z_
רҵ¿Î ÃâÒßѧ Q+:y
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê
LgqQr6y"
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen =RoG?gd{R
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin O)'CU1vMb
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test 'p@f5[t
9. Hybridoma technic 10.Mitogen CMt<oT6.?
11.Dentritic cell 12.Immunoproliferation t R^f]+Up
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ x~5uc$
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨Äļ¸¸öÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ @DN/]P
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦Óᣠw,UE0i9I
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ s,z~qL6&
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ 1"h"(dA
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ PDNl]?
ZpTDM1ro
+QChD*
F/5&:e?( )
Y|Iq~Qy~
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 0vY_
$8tk|uh
DT-VxF6
h
רҵ¿Î ÃâÒßѧ s9- qR_
Ò»¡¢ Ãû´Ê½âÊÍ @N*|w
Kc+
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï HD j6E"
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà HsY5
wC
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ ?UnQ?F(+G<
¶þ¡¢ ÎÊ´ðÌâ &:&'70Ya
1¡¢ TÁÜ°Íϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ CPz<iU
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁÜ°Íϸ°ûºÍЧӦÎïÖÊ¡£ Q,U0xGGz
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆ乲ͬÌص㼰ÓëÁÙ´²µÄ¹Øϵ¡£
RGW@@
4¡¢ ºÎνÁÜ°Íϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ ,H=k5WA4m
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØϵͳ£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ ZW4f "
'uL4ezTtA
YWZ;@,W
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ VjQ&A#
1@]&iZ]
"@V yc6L
רҵ¿Î ÃâÒßѧ j.E=WLKV*
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê xSY"Ru
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR ~\":o:qyc
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA yRXML\Ge
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM kx,.)qKk
¶þ¡¢ ÎÊ´ðÌâ ,!orD1,'
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌص㡣 n!)$e;l
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ ;V,L_"/X
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖƵÄÒìͬµã¡£ ;;0'BdsL`
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆ书ÄÜ¡£ (W}F\P
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ 2<D| {
Tmzbh 9
t2[/eM.G
W!{RJWe
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ hGtz[u#p
>|taU8^|G}
z; GQnAG@
רҵ¿Î ÃâÒßѧ gk6f_0?X'
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê {JE [
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule U1 _"D+XB
5. Autogous mixed lymphoyte reaction A`7(i'i5]
¶þ¡¢ ÎÊ´ðÌâ J[ZHAnmPH
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ jVff@)_S
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ 4=Th<,<
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠ9c@M(U@Yh
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹Øϵ£¿ <6UXk[y
`~XksyT
s= %3`3Fo
w6BBu0,KC
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ [F6)Z[uG
%o?)`z9-
Qs1CK;+zU
רҵ¿Î ÃâÒßѧ 8T1`9ITl:
lHM+<Z
Skr(C5T
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê x}/jh
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance cL9gaD$;)
5. Delayed type hypersensitivity 5*44QV
¶þ¡¢ ÎÊ´ðÌâ w)7y{ya$
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ #Z1%XCt
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ \5a.JfF
3. ¼òÊöHLAÓëҽѧµÄ¹Øϵ¡£ _r:Fmn_%-
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ|dR}S!fmG
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷Óᣠi^DMnvV.
k[f2`o=
}ny7LQ
d88A.Z3w
d*8*9CpO:
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ vn}m-U XA*
8\s#law
jL-2
}XrA
רҵ¿Î ÃâÒßѧ
lie,A
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê t+v%%N_
1. hypersensitivity 2. cluster of differentiation )Fx]
LeI;
3. adhesion molecules 4. supper antigen 5. split tolerance 'vNju1sfk
¶þ¡¢ ÎÊ´ðÌâ kWW2N0~$
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ O50_qu33ju
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ dFBFXy
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ )#i@DHt=
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ ^]sb=Amw
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ /3M8;>@u
$
64up!
m ""+$
hJ(vDv%
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 'Q=;I
רҵ¿Î ÃâÒßѧ fG1iq<~
Ò»¡¢ Ãû´Ê½âÊÍ qb[hKp5K6
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å *;@wPT
5. GVHR TVNgj.`+u!
¶þ¡¢ ÎÊ´ðÌâ @<P2di
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷ÓᣠeN<L)a:J_
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌصãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ SVo ?o|<
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌص㡣 -)(5^OQ
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ %M`48TW)
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ d3:GmB .
0g[ %)C
!~|-CF0z=
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ :&wb+tV
O[VY|.MEk
f|,Kh1{e
רҵ¿Î ÃâÒßѧ %)7t2D
Ò»¡¢Ãû´Ê½âÊÍ ]JkEf?;
.
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å jh/,G5RM9
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ cTGd<
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ kQmkS^R
11. »ìºÏÁÜ°Íϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ To(I<W|{
Èý¡¢ ÎÊ´ðÌâ V<UChD)N`
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ 0{b} 1D
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ 4fs
d5#
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà I]C
Y>'
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ dJgLS^1E
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ _;03R{e*
Uuy$F
*#YZm>h
UiG/Rn
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ YJv$,Z&;HO
Mq$K[]F
'O(=Pz
רҵ¿Î ÃâÒßѧ KZjh<sjX|
Ò»¡¢Ãû´Ê½âÊÍ JVuju$k
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó tle`O)&uo
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁÜ°Íϸ°ûµÄ±íÃæ±êÖ¾ nq{/fD(2
Èý¡¢ ÎÊ´ðÌâ m'NAM%$}J
1. ¼òÊöTÁÜ°Íϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ ^
0.8-RT
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ | @AXW
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ [@Ac#
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ bKpy?5&>
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ 6=;:[
U:TkO=/>:
w!"L\QT
&DMC\R* j
Y ]([K.I=
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ vb=]00c
Ò»¡¢Ãû´Ê½âÊÍ 6o^>q&e}%
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï t.ulG
*
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó ? uYO]!VC
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ i%9vZ
¶þ¡¢ ÎÊ´ðÌâ <'4Wne.z!
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ v8-My1toV
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ } [#8>T
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ sa8O<Ab
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ G^ GIHd
o
iW6O9~
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ tKt}]KHV
Ò»¡¢ Ãû´Ê½âÊÍ QDn_`c
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ 1x_EAHZ>7
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ TAUl{??,
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© h-PJC/>
10¡¢ ÒõÐÔÑ¡Ôñ 7"Xy8]i{z
¶þ¡¢ ÎÊ´ðÌâ edMCj
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 O
H>.N"IG
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ 0G8@UJv6
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 1e[?}q]*
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ }p?,J8=-
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. eI
( S)q
_-vlN
_qE9]mU
vT#R>0@mi
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ B5 /8LEWw
7D<Aa?cv_l
Oey
Ph9^V
רҵ¿Î ÃâÒßѧ P.>fkO1\
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ {qHQ_
_Bl
1. Cytokines 2. adhesion molecules 3. graft versus host reaction Z><+4
'
4. immunologic tolerance 5. Opsonization 3_@IE2dA
Èý¡¢ ÎÊ´ðÌâ 0 @#Jz#?
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷Óᣠ9
5!xJdq
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ aO$0[-A
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ pImq<Z
4. ÃâÒßϵͳɱÉË°Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ O_ r-(wE4
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ ozsd6&z5l
p*W{*wZ_^
n5"i'o{w
5xr2
x(>XM:|
N#-%b"(
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ W
~MNst?
'\QJ{/JV
EQoK\.;
G~
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ !JdZ0l
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ a:P+HU:
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê nd\$Y
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ -^_^ByJe
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û IRLAsb3
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö xTG5VBv
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð 7&etnQJ{
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖƱ¸ÔÀí¡£ , MqoX-+
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ ~Q^.7.-T
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃ濹ԺͱíÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© S^1ZsD.
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ E}zGY2Xx
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ b$Ei>%'/";
$2]>{g
Z1$S(p=)L
qz
)KCEs
(3K,f4S@
xA;)02
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ ,ZYPffu<*
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ {Gh9(0,B?
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ lP4s"8E`h
ifWQwS/,a
Ò»¡¢ Ãû´Ê½âÊÍ 18j>x3tn
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß am'K$s
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò ]"O*&
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô [@pumH>
¶þ¡¢ÎÊ´ðÌâ QXa2qxTc
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ =Y^K
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì Q`O~ f<a
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì r|z B?9Q
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ h*hkl#
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ RP 6<#tq,
Ag{)?5/d_